News

7 Products Boston Scientific is Betting on in 2014: Lotus Transcatheter Aortic Valve Replacement System


Posted in Cardiovascular by Jamie Hartford on February 4, 2014

Lotus Transcatheter Aortic Valve Replacement System

Boston Scientific received CE Mark approval and initiated sales for the Lotus Valve System, a second-generation TAVR technology, in Q4 2013. “Impressions from the commercial accounts we have launched into thus far has been very positive,” Mahoney said. The company will expand roll-out of the product in international markets and initiate an IDE trial in the United States this year. 

Watchman Vessix 

 

 

 

[image courtesy of BOSTON SCIENTIFIC]


Tags:
Printer-friendly version
No votes yet

Login to post comments